$67.27
+0.770 (+1.16%)
At Close: Jun 23, 2026
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
09:05pm, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
* Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are
Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates
08:46pm, Thursday, 24'th Feb 2022
Merit Medical (MMSI) delivered earnings and revenue surprises of 42% and 3.17%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
01:01pm, Thursday, 24'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Adagio Appoints COO David Hering As Interim CEO
Adagio Therapeutics, Inc., (NASDAQ: ADGI) announced th
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
01:06pm, Sunday, 20'th Feb 2022 Benzinga
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
On the regulatory front, the Food and Drug A
Earnings Preview: Merit Medical (MMSI) Q4 Earnings Expected to Decline
08:03pm, Thursday, 17'th Feb 2022 Zacks Investment Research
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) Q3 Earnings and Revenues Top Estimates
10:45pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
McKesson (MCK) delivered earnings and revenue surprises of 14.31% and 3.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Merit Medical (MMSI) Stock For Now
04:35pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
Investors continue to be optimistic about Merit Medical (MMSI) owing to its progress in the WAVE study and a strong product portfolio.
Here's Why You Should Retain Merit Medical (MMSI) Stock For Now
01:04pm, Wednesday, 02'nd Feb 2022
Investors continue to be optimistic about Merit Medical (MMSI) owing to its progress in the WAVE study and a strong product portfolio.
Domino's, Bath & Body Works, among stocks that are oversold, says Chris Senyek
05:18pm, Friday, 21'st Jan 2022
Chris Senyek, Wolfe Research chief investment strategist, joins 'Power Lunch' to discuss which stocks have been oversold and those investors should watch.
Merit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022
09:55pm, Monday, 17'th Jan 2022 GlobeNewswire Inc.
SOUTH JORDAN, Utah, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagno
Merit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022
04:55pm, Monday, 17'th Jan 2022
SOUTH JORDAN, Utah, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnost
Here's Why You Should Retain Merit Medical (MMSI) Stock For Now
03:26pm, Thursday, 23'rd Dec 2021 Zacks Investment Research
Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.
Here's Why You Should Retain Merit Medical (MMSI) Stock For Now
11:30am, Thursday, 23'rd Dec 2021
Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.
WCM Investment Management LLC Sells 48,557 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)
12:32pm, Wednesday, 22'nd Dec 2021 Transcript Daily
WCM Investment Management LLC decreased its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 23.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 161,176 shares of the medical instruments suppliers stock after selling 48,557 shares during the quarter. WCM Investment []
The Embolotherapy Product Market research report help builds up a clear view of the market trends and development, identify major players in the industry and estimate main downstream sectors. Moreover, the Embolotherapy Product Market research report examines competitive developments such
Sign In
Buy MMSI